These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25483993)

  • 1. Modulation of nuclear factor-κB-mediated pro-inflammatory response is associated with exogenous administration of bone marrow-derived mesenchymal stem cells for treatment of experimental colitis.
    Zuo D; Tang Q; Fan H; Shou Z; Liu X; Cao D; Zou Z
    Mol Med Rep; 2015 Apr; 11(4):2741-8. PubMed ID: 25483993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on the interactions between transplanted bone marrow-derived mesenchymal stem cells and regulatory T cells for the treatment of experimental colitis.
    Zuo D; Liu X; Shou Z; Fan H; Tang Q; Duan X; Cao D; Zou Z; Zhang L
    Int J Mol Med; 2013 Dec; 32(6):1337-44. PubMed ID: 24142133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative impact of bone-marrow-derived mesenchymal stem cells on dextran sulfate sodium-induced colitis.
    Nam YS; Kim N; Im KI; Lim JY; Lee ES; Cho SG
    World J Gastroenterol; 2015 Feb; 21(7):2030-9. PubMed ID: 25717235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic guinea pig mesenchymal stem cells ameliorate neurological changes in experimental colitis.
    Stavely R; Robinson AM; Miller S; Boyd R; Sakkal S; Nurgali K
    Stem Cell Res Ther; 2015 Dec; 6():263. PubMed ID: 26718461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats.
    Tanaka F; Tominaga K; Ochi M; Tanigawa T; Watanabe T; Fujiwara Y; Ohta K; Oshitani N; Higuchi K; Arakawa T
    Life Sci; 2008 Dec; 83(23-24):771-9. PubMed ID: 18950645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow mesenchymal stem cells ameliorate colitis-associated tumorigenesis in mice.
    Chen Z; He X; He X; Chen X; Lin X; Zou Y; Wu X; Lan P
    Biochem Biophys Res Commun; 2014 Aug; 450(4):1402-8. PubMed ID: 25010644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis?
    Gonçalves Fda C; Schneider N; Pinto FO; Meyer FS; Visioli F; Pfaffenseller B; Lopez PL; Passos EP; Cirne-Lima EO; Meurer L; Paz AH
    World J Gastroenterol; 2014 Dec; 20(48):18228-39. PubMed ID: 25561790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human umbilical cord mesenchymal stem cells ameliorate mice trinitrobenzene sulfonic acid (TNBS)-induced colitis.
    Liang L; Dong C; Chen X; Fang Z; Xu J; Liu M; Zhang X; Gu DS; Wang D; Du W; Zhu D; Han ZC
    Cell Transplant; 2011; 20(9):1395-408. PubMed ID: 21396175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of thalidomide on trinitrobenzene sulfonate-induced colitis in young rats and its mechanism.
    Xu J; Zheng C; Huang Y; Liang Y
    Chin Med J (Engl); 2014; 127(12):2368-75. PubMed ID: 24931258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
    Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS
    Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine.
    Sala E; Genua M; Petti L; Anselmo A; Arena V; Cibella J; Zanotti L; D'Alessio S; Scaldaferri F; Luca G; Arato I; Calafiore R; Sgambato A; Rutella S; Locati M; Danese S; Vetrano S
    Gastroenterology; 2015 Jul; 149(1):163-176.e20. PubMed ID: 25790743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Adipose-Derived and Bone Marrow Mesenchymal Stromal Cells in a Murine Model of Crohn's Disease.
    Xie M; Qin H; Luo Q; He X; He X; Lan P; Lian L
    Dig Dis Sci; 2017 Jan; 62(1):115-123. PubMed ID: 27107864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of AP‑1 and NF‑κB inhibitors on colonic endocrine cells in rats with TNBS‑induced colitis.
    El-Salhy M; Umezawa K
    Mol Med Rep; 2016 Aug; 14(2):1515-22. PubMed ID: 27357734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic infusion of bone marrow-derived mesenchymal stem cells for treatment of experimental colitis in mice.
    He XW; He XS; Lian L; Wu XJ; Lan P
    Dig Dis Sci; 2012 Dec; 57(12):3136-44. PubMed ID: 22752635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing epithelial engraftment of rat mesenchymal stem cells restores epithelial barrier integrity.
    Yabana T; Arimura Y; Tanaka H; Goto A; Hosokawa M; Nagaishi K; Yamashita K; Yamamoto H; Adachi Y; Sasaki Y; Isobe M; Fujimiya M; Imai K; Shinomura Y
    J Pathol; 2009 Jul; 218(3):350-9. PubMed ID: 19291714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An oral drug delivery system targeting immune-regulating cells ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis.
    Nakase H; Okazaki K; Tabata Y; Uose S; Ohana M; Uchida K; Nishi T; Debreceni A; Itoh T; Kawanami C; Iwano M; Ikada Y; Chiba T
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1122-8. PubMed ID: 11356937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of the cholinergic anti-inflammatory pathway on experimental colitis.
    Bai A; Guo Y; Lu N
    Scand J Immunol; 2007 Nov; 66(5):538-45. PubMed ID: 17953529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the TLR4/NF-κB signaling pathway.
    Zeng Z; Zhan L; Liao H; Chen L; Lv X
    Planta Med; 2013 Jan; 79(2):102-9. PubMed ID: 23250811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological activation of canonical nuclear-factor κB by synergy of tumor necrosis factor α and TNF-like weak inducer of apoptosis in mouse acute colitis.
    Dohi T; Kawashima R; Kawamura YI; Otsubo T; Hagiwara T; Amatucci A; Michaelson J; Burkly LC
    Cytokine; 2014 Sep; 69(1):14-21. PubMed ID: 25022957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.